Sanofi SA

SNYNF

Company Profile

  • Business description

    Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

  • Contact

    46, Avenue de la Great Army
    Paris75017
    FRA

    T: +33 153774000

    E: [email protected]

    https://www.sanofi.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    82,878

Sanofi SA News & Analysis

markets

Globalisation declining? Not in investor portfolios

Morningstar Indexes through a geographic revenue lens.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,000.7041.300.46%
CAC 408,121.070.000.00%
DAX 4024,283.974.43-0.02%
Dow JONES (US)48,441.74306.850.64%
FTSE 1009,865.9731.45-0.32%
HKSE25,801.77111.240.43%
NASDAQ23,452.32144.700.62%
Nikkei 22550,402.39895.181.81%
NZX 50 Index13,508.30174.901.31%
S&P 5006,880.9846.480.68%
S&P/ASX 2008,699.9039.700.46%
SSE Composite Index3,917.3626.920.69%

Market Movers